Close Window Close Window
4th Biosimilars North America
Iselin, New Jersey
15/11/2017 - 16/11/2017
URL:   Click here for the event website.
Organizer:   SMi Group Ltd.
Building on the success of previous events, SMi proudly announces the return of its 4th annual Biosimilars North America Conference, taking place on November 15 and 16, 2017 in Iselin, New Jersey.

The North American biosimilars market continues to grow and has become highly lucrative. As such, pharmaceutical companies continue to find ways to differentiate their products in such a saturated market. Thus, Biosimilars North America 2017 will provide an intelligent meeting to explore novel and innovative strategies to advance biosimilar development, and ensure optimal market access and commercialization opportunities whilst complying with evolving regulatory requirements.

This year, the conference will also explore significant developmental topics within the sector including the impact of FDAs newly implemented biosimilar interchangeability guidelines, the US market access landscape, and biosimilars of orphan drugs.

Key speakers include Harvest Moon Pharmaceuticals Inc, Sandoz, MedImmune, Mylan, Norwegian Medicines Agency, Momenta Pharmaceuticals, Inc, Oncobiologics Inc, FUJIFILM Diosynth Biotechnologies, and more. For more information visit:
Close Window